Department of Infectious Diseases, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Department of Pediatrics, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Arch Pediatr. 2023 Jul;30(5):297-301. doi: 10.1016/j.arcped.2023.03.011. Epub 2023 Apr 24.
One of the challenging risk factors for severe COVID-19 infection is obesity and high body mass index (BMI). In this study we assessed the association between BMI and outcomes of hospitalized pediatric patients with COVID-19 in Iran.
This retrospective cross-sectional study was performed in the biggest referral pediatric hospital in Tehran from March 7 to August 17, 2020. All hospitalized children ≺18 years of age with laboratory-confirmed COVID-19 were included in the study. We evaluated the association of BMI with COVID-19 outcomes (death, severity of clinical course, oxygen therapy, intensive care unit [ICU] admission, ventilator requirement). The secondary objectives were investigating the association of gender, underlying comorbidity, and patient age with COVID-19 outcomes. The limits for obesity, overweight, and underweight were set at BMI >95 percentile, 85≤ BMI ≤ 95, and BMI<5 percentile, respectively.
In total, 189 confirmed pediatric cases of COVID-19 (0.1-17 years) with a mean age of 6.4 ± 4.7 years were included. Overall, 18.5% of the patients were obese and 33% were underweight. We found that BMI had no significant relation with COVID outcomes in pediatric cases but after subgrouping the participants, underlying comorbidities and lower BMI in previously ill children were independently associated with a poor clinical outcome of COVID-19. In addition, the previously ill children with higher BMI percentiles were at a relatively lower risk of ICU admission (95% CI: 0.971-0.998, OR: 0.98, p = 0.025) and better clinical course of COVID-19 (95% CI: 0.970-0.996, OR: 0.98, p = 0.009). The BMI percentile had a statistically significant direct relationship with age (Spearman correlation coefficient= 0.26, p<0.001). When we separated the children with underlying comorbidity, the BMI percentile was significantly lower (p<0.001) in comparison to the previously healthy children.
Based on our results, obesity is not related to COVID-19 outcomes in pediatric patients, but after controlling for confounding effects, underweight in children with underlying comorbidities was more likely to be associated with a poor prognosis of COVID-19.
COVID-19 感染的一个具有挑战性的风险因素是肥胖和高体重指数(BMI)。在这项研究中,我们评估了 BMI 与伊朗住院儿科 COVID-19 患者结局之间的关系。
这是一项回顾性的病例对照研究,于 2020 年 3 月 7 日至 8 月 17 日在德黑兰最大的儿科转诊医院进行。所有实验室确诊的 COVID-19 住院儿童≺18 岁均纳入研究。我们评估了 BMI 与 COVID-19 结局(死亡、临床过程严重程度、氧疗、重症监护病房[ICU]入住、呼吸机需求)之间的关系。次要目的是调查性别、潜在合并症和患者年龄与 COVID-19 结局之间的关系。肥胖、超重和体重不足的界限分别设定为 BMI>第 95 百分位数、85≤BMI≤95 和 BMI<第 5 百分位数。
共纳入 189 例确诊的儿科 COVID-19 病例(0.1-17 岁),平均年龄为 6.4±4.7 岁。总体而言,18.5%的患者肥胖,33%体重不足。我们发现 BMI 与儿科患者的 COVID 结局无显著关系,但在对参与者进行亚组分析后,既往患病和较低 BMI 的儿童与 COVID-19 的不良临床结局独立相关。此外,BMI 百分位较高的既往患病儿童 ICU 入住的风险相对较低(95%CI:0.971-0.998,OR:0.98,p=0.025),COVID-19 临床过程较好(95%CI:0.970-0.996,OR:0.98,p=0.009)。BMI 百分位数与年龄呈显著正相关(Spearman 相关系数=0.26,p<0.001)。当我们将有潜在合并症的儿童分开时,与无潜在合并症的儿童相比,BMI 百分位数显著降低(p<0.001)。
根据我们的结果,肥胖与儿科患者 COVID-19 结局无关,但在控制混杂因素影响后,患有潜在合并症的儿童体重不足更有可能与 COVID-19 的不良预后相关。